CD81 as a tumor target.
暂无分享,去创建一个
Ronald Levy | Shoshana Levy | S. Levy | F. Vences-Catalán | Felipe Vences-Catalán | Caroline Duault | Chiung-Chi Kuo | Ranjani Rajapaksa | C. Kuo | R. Rajapaksa | R. Levy | Caroline Duault | C. Duault
[1] B. Quesnel,et al. Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia , 2016, Oncotarget.
[2] R. Groen,et al. Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab , 2015, Leukemia.
[3] J. Barrett,et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. , 1995, Science.
[4] D. Maloney,et al. Rituximab: Mechanism of action and resistance. , 2002, Seminars in oncology.
[5] R. Cortese,et al. Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model. , 2015, The Journal of antimicrobial chemotherapy.
[6] Robert J. Marinelli,et al. CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. , 2010, Human pathology.
[7] J. Hyman,et al. CD63/Pltgp40: a platelet activation antigen identical to the stage-specific, melanoma-associated antigen ME491. , 1991, Blood.
[8] J. Testa,et al. The pathogenesis of mesothelioma. , 2002, Seminars in oncology.
[9] Wun-Jae Kim,et al. Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray , 2015, PloS one.
[10] Joel S. Freundlich,et al. Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein , 2014, PloS one.
[11] R. Levy,et al. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins , 1990, Molecular and cellular biology.
[12] D. Jeoung,et al. The Tetraspanin CD81 Protein Increases Melanoma Cell Motility by Up-regulating Metalloproteinase MT1-MMP Expression through the Pro-oncogenic Akt-dependent Sp1 Activation Signaling Pathways* , 2014, The Journal of Biological Chemistry.
[13] H. Drummer,et al. Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies , 2014, Front. Microbiol..
[14] S. Chi,et al. CD81 is a candidate tumor suppressor gene in human gastric cancer , 2012, Cellular Oncology.
[15] S. Levy,et al. Reduced fertility of female mice lacking CD81. , 2006, Developmental biology.
[16] I. Weissman,et al. CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. , 2016, The Journal of clinical investigation.
[17] U. Rodeck,et al. Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[18] M. Houghton,et al. Binding of hepatitis C virus to CD81. , 1998, Science.
[19] K. Rajewsky,et al. Isolation of variants of mouse myeloma X63 that express changed immunoglobulin class. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[20] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[21] K. Campbell,et al. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81 , 1997, The EMBO journal.
[22] Ash A. Alizadeh,et al. Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma , 2010, Cell.
[23] M. V. van Zelm,et al. A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression , 2015, Journal of Clinical Immunology.
[24] S. Levy,et al. Normal Lymphocyte Development but Delayed Humoral Immune Response in CD81-null Mice , 1997, The Journal of experimental medicine.
[25] Rosario Garrido,et al. Target-mediated drug disposition and prolonged liver accumulation of a novel humanized anti-CD81 monoclonal antibody in cynomolgus monkeys , 2013, mAbs.
[26] M. Terol,et al. Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients , 2012, Leukemia.
[27] S. Levy,et al. Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81 , 2012, Proceedings of the National Academy of Sciences.
[28] Raymond Liu,et al. Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin , 2009, Journal of Cell Science.
[29] V. Carloni,et al. Tetraspanin CD81-regulated cell motility plays a critical role in intrahepatic metastasis of hepatocellular carcinoma. , 2008, Gastroenterology.
[30] Scott R Granter,et al. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis , 2015, Cell Research.
[31] B. Barlogie,et al. Differentiation stage of myeloma plasma cells: biological and clinical significance , 2017, Leukemia.
[32] Matthew J. Bowman,et al. Knockout of the tetraspanin Cd9 in the TRAMP model of de novo prostate cancer increases spontaneous metastases in an organ‐specific manner , 2013, International journal of cancer.
[33] S. Levy,et al. Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells. , 2015, Cancer research.
[34] M. Scharff,et al. Identification of rare immunoglobulin switch variants using the ELISA spot assay. , 1992, Journal of immunological methods.
[35] Matthew J. Bowman,et al. Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model , 2012, Molecular Cancer Research.
[36] S. Levy,et al. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity , 2003, Nature Medicine.
[37] M. Houghton,et al. Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection. , 2002, Virology.